Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2017-04-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于股票复牌的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the resumption of trading of the company's stock after a suspension due to planning an equity incentive plan. It references a previous suspension announcement and states the stock will resume trading on a specific date. There is no financial data, no detailed report, no voting results, no management changes, or other detailed disclosures. The document is an official regulatory announcement about stock trading status, fitting best under Regulatory Filings (RNS). The document length is short (523 characters), and it is clearly an announcement, not a full report or detailed filing.
2017-04-24 Chinese
关于独立董事公开征集委托投票权的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement regarding the independent director's public solicitation of proxy voting rights for the 2016 Annual General Meeting (AGM) of the company. It includes information about the independent director, the voting agenda related to the 2017 restricted stock incentive plan, the procedures for proxy voting, and the authorization form for shareholders to delegate their voting rights. The document does not contain financial statements or results but focuses on the solicitation of voting rights and proxy instructions for the AGM. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it pertains to proxy voting rights solicitation and voting instructions for shareholder meetings. The document length and content confirm it is not a brief announcement but a full solicitation document related to voting rights for the AGM.
2017-04-24 Chinese
2017年度限制性股票股权激励计划（草案）摘要公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding a 2017 annual restricted stock equity incentive plan for a company, including extensive information on stock grants, conditions, lock-up periods, performance targets, and legal compliance. It includes financial data summaries but primarily focuses on the equity incentive plan details, terms, and procedures. This type of document is not a full annual report, earnings release, or management discussion but rather a regulatory announcement about a stock-based compensation plan. It is not a simple announcement of voting results or a proxy statement, but a detailed disclosure about a stock incentive plan. Such documents typically fall under Regulatory Filings (RNS) as they are compliance disclosures related to equity incentive plans and do not fit other categories like Remuneration Information (DEF 14A) which focus on compensation tables, or Board/Management Information (MANG) which focus on management changes. Therefore, the best classification is Regulatory Filings (RNS). The document length (15,000 characters) and detailed content confirm it is not a brief announcement but a full disclosure document, supporting this classification with high confidence.
2017-04-24 Chinese
2017年度限制性股票股权激励计划（草案）
Board/Management Information Classification · 95% confidence The document is a detailed plan for a restricted stock equity incentive program by 金宇生物技术股份有限公司 (Jinyu Biotechnology Co., Ltd.) for the year 2017. It includes legal references, stock issuance details, eligibility criteria, lock-up periods, performance targets, and procedural rules. The content is focused on management and employee stock incentives, governance of the plan, and related corporate actions. It is not a financial report, earnings release, or regulatory announcement but a comprehensive management-level document about stock-based compensation. This fits best under Board/Management Information (MANG) as it relates to senior management incentives and governance rather than a general governance report or remuneration report. The document length and detail confirm it is the plan itself, not just an announcement or summary.
2017-04-24 Chinese
2017年度限制性股票股权激励计划实施考核管理办法
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '2017年度限制性股票股权激励计划实施考核管理办法' (2017 Restricted Stock Equity Incentive Plan Implementation Assessment Management Measures) issued by the company 金宇生物技术股份有限公司. It outlines the assessment principles, scope, responsibilities, evaluation criteria, procedures, and application of results related to the company's stock incentive plan. There is no indication that this is a financial report, earnings release, regulatory filing, or announcement. It is a governance-related document focusing on internal management and incentive mechanisms. Therefore, it best fits the category of Governance Information (CGR). The document length is 3023 characters, which is relatively short but contains substantive governance content rather than an announcement or summary. Hence, the classification is CGR with high confidence.
2017-04-24 Chinese
内部控制审计报告（2016年度）
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告 2016年度' which translates to 'Internal Control Audit Report for the year 2016'. It is issued by a registered accounting firm (BDO 立信会计师事务所) and addresses the effectiveness of internal controls over financial reporting as of December 31, 2016. The content includes auditor responsibilities, company responsibilities, and an audit opinion on internal control effectiveness. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to internal controls. The document length is 2252 characters, which is relatively short but contains substantive audit content rather than just an announcement or certification. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Hence, the correct classification is AR with high confidence.
2017-04-24 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.